Literature DB >> 7948452

Physical comorbidity and polypharmacy in older psychiatric patients.

J P Lacro1, D V Jeste.   

Abstract

We compared three groups of older psychiatric outpatients on numbers and types of physical illnesses and on number of nonpsychotropic medications. The subjects included 62 patients with Alzheimer's disease (AD), 41 with major depression (MD), and 78 with schizophrenia (SZ). The mean age in this predominantly male population was 68.4 years. Psychiatric diagnoses were based on DSM-III-R criteria. We utilized intake psychiatric assessments, chart reviews, and computerized pharmacy profiles to collect the data. The patients with SZ had significantly lower comorbidity compared to patients with MD, and had a significantly lower number of nonpsychotropic medications prescribed than both the AD and MD groups. These findings may reflect biological differences or may be secondary to differences in psychiatric treatment or in the use of health care resources. Alternatively, the low prevalence of physical comorbidity in SZ may represent a survivor or healthier cohort of patients.

Entities:  

Mesh:

Year:  1994        PMID: 7948452     DOI: 10.1016/0006-3223(94)91220-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  8 in total

Review 1.  A tipping point in drug dosing in late-life schizophrenia.

Authors:  Takashi Tsuboi; Takefumi Suzuki; Hiroyuki Uchida
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

Review 2.  Geriatric psychosis.

Authors:  J P Lacro; D V Jeste
Journal:  Psychiatr Q       Date:  1997

Review 3.  Patient-oriented strategies for the prevention of drug interactions.

Authors:  C P Alderman
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

4.  Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI.

Authors:  A Kumar; Z Jin; W Bilker; J Udupa; G Gottlieb
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

5.  Relative tolerability of Alzheimer's disease treatments.

Authors:  Gustavo Alva; Jeffrey L Cummings
Journal:  Psychiatry (Edgmont)       Date:  2008-11

6.  Bone mass in schizophrenia and normal populations across different decades of life.

Authors:  Jenn-Huei Renn; Nan-Ping Yang; Ching-Mo Chueh; Chih-Yuan Lin; Tsuo-Hung Lan; Pesus Chou
Journal:  BMC Musculoskelet Disord       Date:  2009-01-01       Impact factor: 2.362

7.  Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's.

Authors:  Yang Zhao; Tzu-Chun Kuo; Sharada Weir; Marilyn S Kramer; Arlene S Ash
Journal:  BMC Health Serv Res       Date:  2008-05-22       Impact factor: 2.655

8.  Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital.

Authors:  Alicia Gunterus; Shruti Lopchuk; Christina Dunn; Ronald Floyd; Brad Normandin
Journal:  Ment Health Clin       Date:  2016-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.